ALB and congenital anomaly of kidney and urinary tract: Almost 60% of patients reached the composite end point of disease progression, which was driven by well-known risk factors, including age, a diagnosis other than CAKUT, eGFR at baseline, albuminuria, BP, and serum albumin levels.